FDA set to decide on approval of first-ever mRNA flu vaccine

The US Food and Drug Administration is expected to decide whether to approve the first mRNA-based flu vaccine, a landmark moment for seasonal influenza prevention. The technology, proven during the COVID-19 pandemic, would now be applied to the annual flu shot. No decision date has yet been publicly announced.